NDC 70183-221 – Inpefa
Sotagliflozin 200 mg/1 · Tablet · Oral
Product NDC70183-221
Product details
- Brand name
- Inpefa
- Generic name
- Sotagliflozin
- Labeler
- Lexicon Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA216203
- Marketed since
- May 26, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Sodium-Glucose Cotransporter 2 Inhibitor
Active ingredients
- Sotagliflozin 200 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 70183-221-07 sample | 1 BLISTER PACK in 1 CARTON (70183-221-07) / 7 TABLET in 1 BLISTER PACK | Jan 15, 2024 |
| 70183-221-30 | 30 TABLET in 1 BOTTLE (70183-221-30) | Mar 1, 2024 |
| 70183-221-31 | 1 BLISTER PACK in 1 CARTON (70183-221-31) / 3 BLISTER PACK in 1 BLISTER PACK / 10 TABLET in 1 BLISTER PACK | Dec 1, 2023 |
Other Inpefa products
- 70183-241 Sotagliflozin 400 mg/1 · Tablet · Lexicon Pharmaceuticals, Inc.